Active Surveillance for Localized Prostate Cancer : A New Paradigm for Clinical Management /: A New Paradigm for Clinical Management. (2017)

• Record Type: Book
• Further Information: Note: Laurence Klotz.
• Editors: Klotz, Laurence
• Contents: Table of ContentsChapter 1 Cancer Overdiagnosis and Overtreatment Laurence KlotzChapter 2 Can We Screen and Still Reduce Overdiagnosis? Peter Ka-Fung Chiu and Monique J. RoobolChapter 3 The Role of Fear in Overdiagnosis and Overtreatment Iona HeathChapter 4 Ethical and Legal Considerations in Active Surveillance for Prostate Cancer Lionne D.F. VenderbosChapter 5 Gleason 6 Tumors Should Still Be Labeled As Cancer Angelo M. De Marzo and Jonathan I. EpsteinChapter 6 Risk Based Selection for Active Surveillance Jan F.M. Verbeek, Monique J. Roobol and Ewout W. SteyerbergChapter 7 Surveillance at the Margins: Management of High Volume Gleason 6, PSA > 10, or Gleason 3+4 Laurence KlotzChapter 8 How Should Patients on Active Surveillance be Followed? Frank-Jan H. Drost, Monique J. Roobol, and Leonard P. BokhorstChapter 9 Triggers for Intervention Tuomas Mirtti, Hanna Vasarainen, and Antti RannikkoChapter 10 MR Imaging in Prostate Tumor Volume Assessment: How Accurate? Ivo G. Schoots and Theo H. van der KwastChapter 11 Can MRI Replace Biopsy in Men on Surveillance? Francesco Giganti, Vasilis Stavrinides, and Caroline M. MooreChapter 12 Tissue Based Markers for Risk Prediction Chad A. Reichard and Eric A. KleinChapter 13 International AS Registry: The Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative Sophie M. Bruinsma, Daan Nieboer, Tim Hulsen, Liying Zhang, Rachelle Kirk- Burnnand, Sam Gledhill, and Mark Buzza on behalf of the Movember Foundation's GAP3 Steering CommitteeChapter 14 Better Informed Decision Making to Optimize Patient Selection Lara Bellardita, Paola Dordoni, Letizia De Luca, Julia Paola Menichetti Delor, Riccardo ValdagniChapter 15 How Does QOL Compare Between Surveillance and Active Treatment? Lionne D.F. Venderbos, Stephanie Danielle Brandhof, and Ida J. KorfageChapter 16 The Potential Benefits of Diet and Physical Activity among Active Surveillance Patients with Low-Burden Prostate Cancer Stacey A. Kenfield, David Tat, and June M. ChanChapter 17 Is there a Role for Pharmacologic Manipulation to Prevent Progression in Men on Active Surveillance? The Role of 5-ARIs, Statins, and Metformin Roy Mano and David MargelChapter 18 The Update of Active Surveillance around the World: Utilization and Outcomes Jeffrey J. Tosoian, Ridwan Alam, Abbey Lepor, Stacy LoebChapter 19 Tissue Preservation – Active Surveillance and Focal Therapy as Complimentary Strategies Juan Gomez Rivas and Mark EmbertonChapter 20 The Economics of Active Surveillance for Prostate Cancer Robert B. Lurvey and Marc A. Dall'EraChapter 21 Research Questions in Active Surveillance Laurence Klotz.
• Edition: Second edition
• Publisher Details: Cham : Humana Press
• Publication Date: 2017
• Copyright Date: 2018
• Extent: 1 online resource (250 pages)
• Subjects: Medicine; Medical -- Oncology; Medical -- Biochemistry; Medical -- Geriatrics; Oncology; Radiology; Geriatric medicine; Urology; Oncology ; Radiology, Medical; Geriatrics; Medical -- Urology; Urology & urogenital medicine
• Languages: English
• ISBNs: 9783319627106
• Related ISBNs: 9783319627090
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.